Protein
The "low protein extends life" argument from animal studies has been turned against midlife adults who actually need more protein, not less. The resolution is mostly about how you eat it: the dose that maximises muscle building per meal sits close to the dose that, in mechanistic studies, pushes artery-wall immune cells toward plaque-promoting overdrive — so timing, distribution and amino-acid composition matter more than total grams.
Protein is the nutrient where cohort data and mechanistic biology give the most contradictory advice. Both camps have a point, and the mechanism below suggests how they fit together — though the human outcome data are less tidy than either side claims.
The biochemistry, briefly
Two opposing nutrient-sensing enzymes sit at the centre of the cell's build-or-recycle decision. The full mechanism — and how it sets the rate of ageing — lives under deregulated nutrient sensing; what follows is the short version the protein argument needs.
mTOR (mechanistic target of rapamycin) — the anabolic, pro-growth sensor. Its mTORC1 complex integrates growth factors, energy status and — most importantly here — amino acid availability, and the single most potent nutrient trigger is the branched-chain amino acid leucine.[1] Once active, mTORC1 drives protein synthesis and the building of new ribosomes — and simultaneously switches off autophagy, the cell's recycling-and-cleanup program.[2]
AMPK (AMP-activated protein kinase) — the catabolic, low-fuel sensor. It responds to a falling energy charge — fasting, a caloric deficit, mechanical loading — and when active it stimulates glucose uptake, fat oxidation, and the building of new mitochondria, switches mTORC1 off, and initiates autophagy. In cultured muscle cells, mechanical loading alone is enough to activate AMPK and inhibit mTOR.[3]
The hyperfunction theory of ageing — that ageing is the unabated continuation of growth programs into late life — treats chronic mTORC1 activation as the central pathological signal, with AMPK activation (via fasting, exercise, or a low energy state) as its physiological counterweight.[4] Both extremes are harmful: continuous anabolic drive is linked to atherosclerosis, cancer and senescence; continuous catabolic drive produces frailty, sarcopenia and immune failure.
The leucine threshold and the macrophage problem
Two numbers anchor everything that follows.
Number one — the "muscle full" threshold. Maximally stimulating muscle protein synthesis (MPS) in a single meal takes roughly 0.4 g of high-quality protein per kg body weight (~25–30 g for an average adult) — the dose at which the response plateaus in older men, about two-thirds more than the ~0.24 g/kg that saturates it in young men, so it is a conservative target at any age.[5] That dose delivers roughly 2.5–3.0 g of leucine, and leucine is usually named as the trigger — though the review that tested that idea directly found 16 study arms supporting it and 13 against, and scopes it to older adults eating isolated proteins rather than whole food.[6] Beyond this dose, doubling the protein in one sitting doesn't double the synthesis response.[7]
This is an efficiency threshold, not a hard ceiling (Moderate). A quadruple-isotope tracer trial in 36 young active men, twelve per arm, found that 100 g of protein after exercise produced a greater and longer-lasting muscle-building response than 25 g — roughly 20% higher synthesis over the first 4 hours and ~40% higher over the following 4–12 hours — with only minor increases in amino acid oxidation; one author was a dairy-industry employee, though the company had no role in funding, data or analysis.[8] So ~0.4 g/kg per meal maximises efficiency; protein above it is used more slowly, not wasted.
Number two — the macrophage threshold. The dose that saturates MPS sits close to the dose that activates mTORC1 in macrophages, the immune cells that clear fat from artery walls. Eating more than ~25 g protein per meal, or chronically more than ~22% of total energy as protein, raises postprandial plasma leucine into the 100–300 μM window that drives macrophage mTORC1 activation (Moderate, mechanistic).[9] The mechanism: macrophages need autophagy to clear oxidised LDL from the arterial wall, and mTORC1 activation shuts that autophagy off. Macrophages unable to clear their lipid cargo become foam cells; foam cells become plaque. In male mice bred to develop atherosclerosis, leucine content was both necessary and sufficient for the effect: adding leucine to a moderate-protein diet raised lesion area, while adding the same amount of nitrogen as other amino acids did not. The authors note most of their animals were male, so the sex generality is untested.
Read the threshold for what it is: the human arms were 14 and 9 people, the endpoint was a signalling marker in circulating immune cells rather than plaque or events, and the 100–300 μM window was mapped in cultured human macrophages. It is a well-made mechanistic case, not a demonstrated clinical dose.
Read together, the two thresholds explain why "more protein is always better" is wrong without "less is better" being right. Eating the hypertrophy dose once or twice a day around training is one regime; eating 60–80 g of protein at every meal is a different drug.
What the human data actually says
The age-dependent flip. In a 6,381-adult analysis of US national nutrition survey data, high protein intake in adults aged 50–65 was associated with about 4× higher cancer mortality and 75% higher all-cause mortality — an effect driven by animal protein.[10] Above age 65 the relationship inverts and high protein becomes protective — with one exception the same paper reports at every age, a large rise in diabetes mortality, though on numbers too sparse to quantify usefully. This age-dependent flip frames much of what follows, but it should be held loosely: it comes from a single survey analysis built on one day of self-reported diet recall, its all-cause result in the 50–65 band only just clears significance, and the two much larger pooled analyses below find no such flip at all. It is a hypothesis that organises the field, not a settled feature of it.
The population-level mortality signal favours protein, especially plant protein. The largest pooled analysis to date — 32 prospective cohorts, 715,128 participants, 113,039 deaths — found higher total protein intake associated with slightly lower all-cause mortality, with the clearest benefit for plant protein: each additional 3% of energy from plant protein tracked with about 5% lower all-cause mortality (Moderate, observational).[11] The apparent harm of animal protein concentrates in red and processed meat and in people with other lifestyle risk factors. In the Nurses' Health and Health Professionals cohorts, the animal-protein cardiovascular-mortality risk was confined to those with at least one lifestyle risk factor, and substituting just 3% of energy from processed red meat with plant protein associated with 34% lower mortality (Moderate, observational).[12]
The age direction is not settled. A 2026 analysis of 19,420 UK Biobank participants followed for up to 16 years found that people eating 1.8 g/kg/day or more had about 21% more major cardiovascular events, 39% higher all-cause mortality and 73% higher cardiovascular death than those eating less — and the excess in major cardiovascular events (the only outcome the abstract splits by age) concentrated in the older half of the cohort, over 55, with no significant signal below it (Moderate, observational, and the opposite age pattern to Levine).[13] Two caveats keep this from settling anything either: the cohort is nearly three-quarters women with a median age of 54, so the under-55 group is small and its null result imprecise; and 1.8 g/kg/day is a high habitual intake that in an unselected population tends to travel with other things. What it does establish is that the cardiovascular mechanism above has a human outcome signal behind it, at a daily intake the practical targets further down reserve for specific and time-limited contexts rather than for permanent use.
And the endpoint matters as much as the exposure. On a harder endpoint than mortality the picture reverses. Following 48,762 women from before age 60 for three decades, and asking not who died but who reached old age free of eleven chronic diseases with intact cognition, physical function and mental health, every protein source tracked with better odds — including animal protein. Per 3% of daily energy, the odds of healthy ageing rose about 5% for total protein, 7% for animal protein, 14% for dairy protein and 38% for plant protein, and swapping 3% of energy from animal protein, dairy, carbohydrate or fat to plant protein raised them 22–58% (Moderate, observational).[14] Only 7.6% of the cohort met the healthy-ageing definition, so this is a demanding endpoint — and it is the strongest evidence on the page that the plant-protein preference is about what protein comes with, not about eating less of it.
The plant vs animal IGF-1 paradox. It's widely assumed animal protein raises IGF-1 more than plant protein. A tightly controlled isocaloric high-protein trial disagrees: over six weeks in 37 adults with type 2 diabetes, plant and animal protein produced similar increases in bioavailable IGF-1 — about 14% either way — and similar improvements in liver fat, insulin sensitivity and adiposity (Weak, one small trial in a metabolically distinct population).[15] If that holds, the plant advantage is probably not about lower IGF-1 — more likely methionine and leucine density (next section), the surrounding food matrix (fibre, phytochemicals, lower saturated fat), and the carcinogens that come with red and processed meat.
The ceiling for healthy training adults. Intakes up to 1.6 g/kg/day support performance and recovery in active adults without metabolic detriment.[16] A meta-analysis of 49 supplementation studies (1,863 participants) found resistance-training gains in fat-free mass plateaued at about 1.62 g/kg/day (95% CI 1.03–2.20 — the range in which the true value most plausibly lies, and a wide one) (Strong),[17] and the International Society of Sports Nutrition puts the exercising range at 1.4–2.0 g/kg/day.[18] This is the upper bound for healthy training adults in ordinary conditions — the same position stand allows 2.3–3.1 g/kg for trained lifters in a caloric deficit, where the goal is holding onto lean mass. What the bodybuilding community routinely exceeds is the everyday number, without evidence that the excess buys anything beyond body composition.
The older-adult consensus. Adequate protein in older adults protects against sarcopenia, frailty and falls. The international PROT-AGE consensus is 1.0–1.2 g/kg/day for healthy older adults, rising to 1.2–1.5 g/kg with acute or chronic illness and up to 2.0 g/kg in severe illness, injury or malnutrition — with the group's own exception that older people whose kidney function has fallen below an estimated filtration rate of 30 mL/min/1.73 m², and who are not on dialysis, may need to limit intake instead.[19][20] The European clinical nutrition society (ESPEN) expert group reached the same numbers independently — at least 1.0–1.2 g/kg for healthy older people, 1.2–1.5 with acute or chronic illness[21] — and its intensive-care guideline notes that about 1.3 g/kg/day can be delivered progressively during critical illness[22], guidance since revised[23] (Moderate, expert consensus).
The historical RDA of 0.8 g/kg (0.83 g/kg is the WHO/FAO/UNU safe level) is widely viewed as inadequate for skeletal preservation past midlife — and even that floor may be low. Indicator-amino-acid-oxidation studies, which avoid the long adaptation of the old nitrogen-balance method, put the requirement well above the RDA — an average requirement of 0.93 g/kg and a recommended intake of 1.2 g/kg, about 40% and 50% higher than the standard figures, though measured in only eight young men[24]; the same technique applied to men over 65 also put the requirement above the current estimate[25]. Those breakpoints may reflect maximal anabolism rather than a true minimum (Moderate, contested method).
Adding protein with resistance training measurably rebuilds ageing muscle. Pooling 10 randomised trials in 1,154 older adults, whey raised appendicular muscle-mass index against placebo, and whey combined with resistance training raised grip strength — a moderate effect on each, and the two results come from different comparisons rather than from one[26]. A network meta-analysis of 78 trials in 5,272 participants then ranked whey first of all protein sources on muscle mass, grip strength and walking speed[27] (Strong for protein-plus-exercise; protein-alone effects are smaller).
Macronutrient ratio matters, not just total protein. In DNA-repair-deficient mice — a model of accelerated ageing — a high-protein, low-carbohydrate diet shortened lifespan by 18% in males and 36% in females, while low-fat/high-carbohydrate and low-protein/high-carbohydrate diets had no lifespan-shortening effect. The mechanism the authors identify is transcriptional: extra protein accelerated the selective loss of expression of long genes, the signature of DNA-damage-driven transcription stress, alongside markers of tissue injury and inflammation.[28] The implication isn't that protein is poison — it's that protein at the expense of carbohydrate, especially in a sedentary context, is not the longevity diet.
The age-dependent pivot
Whatever the cohort debate, protein needs rise in late middle age, and most guidance is built around that shift.
| Life stage | Dominant threat | Daily protein | Per-meal dose | Rationale |
|---|---|---|---|---|
| Midlife (30–65), sedentary | mTOR hyperfunction, atherosclerosis, oncogenesis | 0.8–1.2 g/kg | 25–30 g across 3 meals | Suppress chronic mTOR/IGF-1 signalling; preserve autophagic flux |
| Midlife (30–65), actively training | Maintaining muscle + cardiometabolic balance | 1.2–1.6 g/kg | 25–40 g, with leucine peri-training | Match training stimulus without exceeding the macrophage threshold every meal |
| Late life (≥65) | Sarcopenia, frailty, immunosenescence | 1.0–1.5 g/kg | ~0.4 g/kg × 3 meals — 25–30 g at 65–75 kg, 30–40 g above that | Overcome anabolic resistance; preserve function |
| Acute illness / recovery | Cachexia, post-surgical catabolism | 1.5–2.0+ g/kg | distributed + clinical guidance | Force positive nitrogen balance |
Anabolic resistance is the mechanism behind the late-life pivot. Older skeletal muscle is materially less responsive to a given dose of amino acids, so reaching the synthesis plateau takes about two-thirds more than the young-adult dose — 0.4 against 0.24 g/kg.[29] The daily leucine requirement moves with it: measured directly in adults over 60, it comes out at about 78 mg/kg/day, more than twice the 34–39 mg/kg currently recommended.[30]
The geriatric per-meal target of 30–40 g — and the recommendation to add a pre-sleep protein feed of ~40 g to counteract the overnight catabolic window — is downstream of that physiology.[31] That figure sits at the assertive end of the range: it follows from 0.4 g/kg at 75–100 kg body weight, while consensus guidance and the review above both put the sufficient dose at 25–30 g. So 40 g is for those at the top of the weight range; a lighter older adult can reasonably sit at 25–30 g.
Protein source: why plant generally beats red meat, mechanistically
The clearest mechanistic case against red and processed meat in volume runs through two channels: amino acid composition (specifically methionine and leucine density) and direct carcinogenicity of preservation byproducts.
Methionine restriction and the methylation cycle
Methionine is a sulfur-containing essential amino acid that is highly concentrated in skeletal muscle meat, poultry, eggs and dairy, and scarcer in legumes. Across yeast, worms, flies and rodents, restricting dietary methionine — independent of total caloric restriction — extends lifespan and improves metabolic health; in rats it added about 30% to lifespan. No primate has been tested, so the step from this evidence to a human recommendation is an inference, not a finding.[32] The mechanism: methionine is the precursor for S-adenosylmethionine (SAM), the cell's universal methyl donor. High SAM stimulates mTORC1; low SAM is read as nutrient deprivation and suppresses it. Methionine restriction also induces FGF21, raising energy expenditure via brown-fat uncoupling.
The processed and red meat case
The colorectal cancer signal for processed and unprocessed red meat is independent of the mTOR story and has stood up across cohorts. Each 50 g/day of processed meat associates with an 18% increase in colorectal cancer risk, and each 100 g/day of unprocessed red meat with about a 17% increase.[33] Processed meat is in the WHO cancer agency's Group 1 (carcinogenic to humans); unprocessed red meat is Group 2A (probably carcinogenic). See Foods to limit for the wider harm signal beyond what protein per se contributes.
A more useful comparison table
Leucine and methionine content vary widely across protein sources, and that variation — not total grams — is what shifts a source's longevity-versus-hypertrophy profile. The isolate figures below are measured; the whole-food rows are indicative, from general composition data.[34]
| Source | Leucine (per 25 g protein) | Methionine | Limiting AA | Longevity/hypertrophy profile |
|---|---|---|---|---|
| Whey isolate | Very high (~2.7 g) | High | None | Potent MPS trigger; ideal peri-training; problematic as continuous high-volume basal source |
| Beef (lean) | High (~2.0 g) | High | None | Drives MPS and expands SAM pool; methionine load argues for glycine balancing |
| Eggs / poultry / fish | High | High | None | Complete and well-tolerated; cohort signal far weaker than red meat's, though mixed for eggs and poultry |
| Soy isolate | Moderate (~1.7 g) | Low | Methionine | Complete on other counts; low methionine softens the SAM/mTOR load |
| Pea / lentil / bean | Moderate (~1.8 g) | Low | Methionine | Functions as a natural methionine-restriction mimetic |
| Collagen / gelatin | Very low | Very low | Tryptophan, leucine | Poor for direct MPS; rich in glycine — see methionine buffer below |
The practical reading: lean fish, eggs, yogurt and poultry sit in a different category from red and especially processed meat. The "animal protein is bad" blanket has always been an over-read of cohorts that mostly measured red and processed meat consumption. "Different category" is not the same as "clean", though — pooling 33 cohorts and 2.2 million people, the highest egg intakes carried no higher all-cause mortality than the lowest, but each extra egg a week tracked with about 2% higher all-cause and 4% higher cancer mortality[35], and a 2025 Italian cohort found more than 300 g of poultry a week associated with higher mortality than under 100 g (Weak, single cohort)[36]. Fish and fermented dairy are the two with consistently favourable data.
Protein quality scoring, and why plant matches animal in practice
Two formal scores rate protein quality. PDCAAS — the current US/Canada regulatory standard — measures fecal digestibility and is capped at 1.0, which flatters plant proteins and undersells the best animal ones. DIAAS (FAO 2013) is the more accurate successor: it uses ileal digestibility of each individual amino acid and is uncapped for single ingredients, though the FAO still truncates it at 100 when scoring mixed meals and sole-source foods. On DIAAS, several animal proteins score ≥1.0 (whole milk, egg, casein, much meat), whey and soy land in the "high quality" band (≥0.75), and many plant isolates — pea, rice, wheat, hemp, oat, fava — fall below 0.75, with potato protein a notable plant exception at the top of the scale (Moderate, FAO methodology plus digestibility modelling).[37]
That scoring gap mostly disappears in real outcomes once total quantity and leucine are matched. Habitual vegans and omnivores matched at ~1.6 g/kg gained similar muscle size and strength over 12 weeks of resistance training[38], and a mycoprotein-rich vegan high-protein diet (~1.8–2.0 g/kg) matched a protein-matched omnivorous diet for muscle protein synthesis and 10-week hypertrophy[39] (Moderate; small, mostly young samples). A plant blend came close to milk protein for acute muscle protein synthesis, though with 24 people split between two groups the difference was merely not significant rather than shown absent — and milk still raised circulating essential amino acids about twice as much.[40] The caveat is age: in older adults with anabolic resistance, an omnivorous meal can beat an isonitrogenous vegan meal for acute MPS, so plant eaters past midlife should lift their absolute dose and lean on blends.
Glycine, collagen, and the methionine buffer
The cleanest practical lever for omnivores is glycine.
Glycine is abundant in connective tissue (collagen, gelatin, skin, bone, bone broth) and largely absent from modern Western diets that rely on skeletal muscle meat. The liver enzyme glycine N-methyltransferase (GNMT) clears excess methionine by transferring a methyl group from SAM onto glycine, producing sarcosine. Dietary glycine therefore acts as a SAM-buffering, methionine-restriction mimetic.[41]
In the NIH Interventions Testing Program, 8% dietary glycine extended lifespan in male and female heterogeneous mice across three independent test sites — a high bar for replication, though the effect was small: median lifespan rose about 6% in males and 4% in females, and one of the three sites only just reached significance.[42] Sarcosine, the GNMT methylation product, declines with age and independently induces autophagy in vitro and in vivo.
The practical version: if your protein backbone is meat-heavy, eat the connective tissue too — bone broth, slow-cooked stews with cartilaginous cuts, gelatin desserts, or 5–10 g of plain glycine daily. Hydrolysed collagen works too, but at about a fifth glycine by weight it takes roughly 25–50 g of collagen to match a 5–10 g glycine dose. The collagen isn't building your tendons via mystical mechanism; the glycine is buffering your methylation cycle. No human trial has tested glycine as a methionine buffer against any clinical outcome — this is a mechanistic bet, and a cheap and safe one.
Practical protein targets
Daily total
- Sedentary midlife adult: 0.8–1.2 g/kg/day
- Active midlife adult: 1.2–1.6 g/kg/day
- Older adult (≥65): 1.0–1.5 g/kg/day — the PROT-AGE floor is 1.0–1.2, rising to at least 1.2 for those who exercise.[43]
- Hypertrophy phase, or older adult training hard, in a caloric deficit, or recovering from acute illness or surgery: 1.6–2.0 g/kg/day — a setting for the phase, not a permanent one
- On a GLP-1 receptor agonist: this is a drug-induced caloric deficit, but the joint guidance from four American nutrition and obesity societies is more conservative than the 1.6–2.0 band above and the figures circulating online. It records the adult reference intake of 0.8 g/kg/day, notes that targets of 1.2–1.6 g/kg/day have been proposed during active weight reduction, warns that using actual body weight rather than fat-free mass can significantly overestimate protein needs in obesity, and states that sustained intake at or above 2 g/kg/day should be avoided.[44] Where body composition is known, 1.5 g per kilogram of fat-free mass is the better anchor; where it is not, the advisory's practical fallback is an absolute 80–120 g/day, and it is blunt that no protein target preserves muscle without structured resistance training. See Ozempic-class drugs.
A 75 kg person at the active-midlife target lands in the 90–120 g/day band; an older adult on the geriatric target lands in the 75–115 g/day band depending on health status.
How to hold the upper bands against the 1.8 g/kg signal. The only human outcome cohort on this page that tests a daily threshold found more cardiovascular events, and higher mortality, at and above 1.8 g/kg/day, with the cardiovascular-event excess concentrated in people over 55. The 1.6–2.0 g/kg targets are not a contradiction of it, because they are not habitual settings: they come from short-term trials and clinical guidance in defined contexts — a hypertrophy block, a caloric deficit carried with resistance training, convalescence from illness or surgery — and the one guideline here that speaks to a habitual ceiling, the GLP-1 advisory, draws it at sustained intake below 2 g/kg/day. So the upper band is somewhere you go for a reason and come back from, and the sports-nutrition 2.3–3.1 g/kg deficit figure is a dieting lifter's tool, not a way to live. Past 55 and outside one of those contexts, nothing on this page supports sitting above ~1.8 g/kg/day year after year, and the one cohort that looked found it tracked with harm.
Per-meal distribution
- Target ~0.4 g/kg per meal (≈25–30 g for most adults), which delivers roughly 2.5–3.0 g of leucine.
- Distribute across 3–4 meals rather than loading into one or two — a reasonable heuristic, not a settled fact (Weak / preliminary). It rests largely on one small crossover trial in which even distribution (~30 g × 3) raised 24-hour MPS ~25% versus a skewed pattern[45], n=8, two of whose authors were paid speakers for the National Cattlemen's Beef Association. Later trials in older adults found no difference between even and skewed distribution[46], and no long-term trial shows distribution alone changes muscle mass.[47]
- Older adults: per-meal dose rises to roughly 0.4 g/kg to overcome anabolic resistance — 25–30 g at 65–75 kg, 30–40 g above that. Three such meals is about 1.2 g/kg/day, inside the 1.0–1.5 band; a 40 g pre-sleep feed on top counts toward the same daily total and lifts it to roughly 1.6–1.8 g/kg/day, above the band, so take it on days the total allows or during a deliberate higher-protein phase.
- Add a pre-sleep 40 g feed, particularly if older or in a hypertrophy phase — overnight is the longest catabolic window of the day. Pre-sleep casein raised overnight muscle protein synthesis about 22% in young men after an evening training session, a result that only just reached significance[48], and in 48 older men the effect appeared only at 40 g — 20 g, with or without added leucine, did nothing[49]. Twelve weeks of pre-sleep protein added to muscle and strength gains in young men[50] (Moderate). The benefit shows up when the pre-sleep dose adds to total intake rather than just redistributing it, and the long-term muscle benefit is not yet shown in older adults.
- Don't routinely exceed ~0.4 g/kg per meal multiple times a day — 25–30 g for most adults — unless you're training around it. A 250–300 g steak carries 60–80 g of protein — well past the point where extra grams still buy efficient muscle building, and into the range that pushes plasma leucine toward the macrophage-mTORC1 window.
Source priorities
Anchor the backbone with: fish, legumes (with or without grain pairing), yogurt and kefir, eggs, poultry, soy (tofu, tempeh, edamame), nuts and seeds.
Use occasionally: unprocessed red meat (at most about 3 servings/week, roughly 350–500 g cooked; lower if family history of colorectal cancer or cardiovascular disease), cheese in small amounts, whey or plant protein powder around training.
Limit aggressively: processed meats (Group 1 carcinogen — see Foods to limit for the dose-response).
Add intentionally: glycine via bone broth, gelatin, or plain glycine powder (5–10 g/day) if your animal protein intake is meat-heavy.
Protein and training
Around resistance sessions
Resistance exercise transiently activates AMPK locally — the muscle is in an energy crisis during contraction — and only swings into the mTOR-dominant, MPS-driven repair phase once exogenous amino acids arrive. Pooling 21 randomised trials, 20–40 g of whey around a resistance session raises muscle protein synthesis and activates the AKT/mTOR pathway.[51] The practical implication:
- 20–40 g of high-quality protein within ~2 hours of a resistance session — this is where the "muscle full" threshold actually buys muscle, because the mechanical stimulus has primed the tissue. Whey is fast and complete; food works fine if you eat a normal protein-containing meal within the window.
- Per-session leucine ~2.5–3.0 g — corresponds to ~25 g whey or ~40 g most whole-food sources.
- The anabolic window is hours, not the legacy "30 minutes". Restricting the analysis to trials that actually randomised protein before versus after each session, over at least four weeks, found no difference in lean mass or upper-body strength either way; with only five such trials this is weak evidence, but there is none for the idea that sooner is better.[52]
Concurrent training: organising the AMPK and mTOR stimuli
For people doing both endurance and resistance work, separating the two physiological states is a reasonable signalling heuristic rather than a demonstrated advantage (Weak / mechanistic). The largest synthesis to date — an umbrella review of 17 meta-analyses covering 144 studies and 1,492 participants — found combining endurance and resistance work produced strength, power and hypertrophy comparable to resistance training alone, better aerobic capacity, and no significant effect of training sequence at all.[53] Treat what follows as a way to organise training you were doing anyway, not as a cost you pay for getting the order wrong.
- Zone 2 / longer aerobic sessions in a fasted or near-fasted state raise fat oxidation during the session and are the natural place for the low-fuel, AMPK-dominant state. They do not appear to buy extra mitochondrial adaptation: pooling 19 randomised trials of training with low carbohydrate availability found no effect on the two standard markers of mitochondrial biogenesis, and the one positive subgroup required glycogen depletion far beyond anything an overnight fast produces.[54] Don't pre-load these with protein.
- Resistance training paired with post-workout protein directs the leucine bolus to muscle that has been primed to use it. Don't spend it on cardio.
- Stacking the two on the same day or on alternate days both work.
See Resistance training for programming, Zone 2 for the aerobic side, and VO₂ max for the higher-intensity component.
BCAA supplements
Isolated branched-chain amino acid supplements (leucine, isoleucine, valine) are less effective than whole protein for muscle building. BCAAs alone trigger the mTOR signal without supplying the other essential amino acids needed to assemble a complete protein, so the synthesis response is limited and can even draw on muscle breakdown to fill the gaps.[55] The supplement industry's enthusiasm for BCAAs is older than the evidence justifying it.
Cyclical eating: TRF, protein cycling, and why blind restriction fails
Why the chronic state matters
Continuous feeding from morning to night plausibly keeps mTORC1 downstream signalling elevated and AMPK suppressed, flattening the daily oscillation between them — and a recent systems model extends that logic to NAD⁺ depletion, falling sirtuin activity and epigenetic drift (Weak / theoretical). Its authors present it as a set of testable predictions rather than a demonstrated pathway, and built it for the prolonged anabolic signalling of elite sport rather than ordinary eating.[56]
Time-restricted eating — confining all caloric intake to a consistent 8–12 hour window — is meant to restore that oscillation without requiring any change in total calories or protein.[57] During the fasting window, AMPK rises, autophagic flux increases and NAD⁺ recovers — mechanisms established largely in animals, with human data still sparse. Whether the mTOR response to the next meal is genuinely sharpened by the fast, as is sometimes claimed, has not been tested in people. See Fasting and time-restricted eating for the full evidence on protocols, durations, and who shouldn't fast.
Protein cycling
Once daily intake is appropriate for your life stage, an additional layer is one or two deliberately low-protein days per week — intake below ~0.8 g/kg, with calories from carbohydrate and fat — to drop systemic leucine long enough to re-enable macrophage autophagy, while resistance training holds muscle through brief amino acid deficits. As a discrete intervention this has no human-outcome trials at all; the rationale is extrapolated from the leucine-threshold and autophagy biology above. Reasonable for people who tolerate it and keep training, but not established.
Why "just eat less protein" backfires
The Protein Leverage Hypothesis is the most important behavioural idea in this literature. Humans regulate protein intake to a roughly fixed daily target; if the diet is protein-dilute, total calorie intake rises until that target is met (Moderate for the effect on calorie intake, Weak for the step from there to obesity).[58] The first half replicates well — a pre-registered analysis of 11,152 adults found calorie intake rising measurably as protein density fell — but that study explicitly could not test whether the effect carries through to body weight, and the leverage explanation for obesity is contested against simpler hedonic accounts.[59] The practical upshot still holds: "eat less protein for longevity" in an ultra-processed, protein-dilute food environment risks raising calorie intake rather than lowering protein. Structured approaches (time-restricted eating, protein cycling) work around this; blind restriction does not.
What's overhyped, and what's just wrong
Overhyped
- Massive protein doses every meal. Beyond ~0.4 g/kg per meal the extra is used less efficiently, and eaten chronically every meal it mainly keeps postprandial leucine high.
- BCAA supplements for muscle building, as discussed above.
- "Animal protein is bad" as a blanket claim. Fish and fermented dairy have consistently favourable cohort data, and eggs and poultry are far from the red-meat signal even if their own data are mixed.
Just wrong
- The 0.8 g/kg RDA as a target for midlife and older adults. It is a floor against overt deficiency, not an optimum; the consensus figures above sit well above it.
- "Protein damages kidneys." True only in pre-existing chronic kidney disease, where current guidance is about 0.8 g/kg a day in stages 3–5 and, at any stage, avoiding more than 1.3 g/kg in people at risk of progression, with higher targets considered for older people who are frail or sarcopenic (a weak recommendation on low-certainty evidence).[60] In healthy kidneys, intakes well above the RDA are tolerated long-term without harm (Strong): a meta-analysis of 28 randomised trials found high-protein diets did not adversely change kidney function — the change in filtration rate did not differ from controls (SMD 0.11, a trivial standardised difference) — though the senior author has received dairy- and beef-council funding.[61]
- "You can only absorb 30 g per meal." Conflates absorption with efficiency. The body absorbs far more than 30 g, and — see Trommelen above — muscle protein synthesis does not saturate either; it just gets less efficient per gram beyond roughly 0.4 g/kg. Excess is used more slowly, metabolised, oxidised, or — see the macrophage section — channelled into less helpful places.
Bone, weight, and frailty
Protein does not harm bone — it modestly helps (Moderate). The "dietary acid load leaches calcium from bone" idea has not held up. A systematic review found protein above the RDA is not harmful and is modestly protective of lumbar-spine bone density[62] (funded by the National Osteoporosis Foundation). In older adults, pooled cohorts linked higher protein intake to about 11% fewer hip fractures (hazard ratio 0.89, 95% CI 0.84–0.94).[63]
Higher protein helps during weight loss (Strong). Higher-protein, energy-restricted diets preserve more lean mass and produce greater fat loss; pooling 24 randomised trials in 1,063 people, the higher-protein arms lost about 140 kcal/day less resting energy expenditure than the standard-protein arms — dieting slows metabolism either way, and more protein slows it less, though the plausible range around that figure is wide (roughly 16 to 269 kcal/day)[64]. In older adults, ≥1.0 g/kg/day during weight loss retained more lean mass.[65] Protein also has the highest thermic effect of any macronutrient — roughly a quarter of its energy goes to digesting and processing it, against under a tenth for carbohydrate and almost none for fat — and it is the most satiating. This is why protein matters most exactly when calories are being cut — including on a GLP-1 receptor agonist.
The frailty caveat (Weak / preliminary). Following 1,868 older adults who already had two or more chronic conditions, those in the top third of protein intake were about a third less likely to become frail than those in the bottom third (hazard ratio 0.66) — but among those who had already become frail, higher protein tracked with higher subsequent mortality, on only 83 deaths.[66] The reasonable reading: protein helps prevent frailty but may not rescue someone already deep in it — though everyone in this cohort was multimorbid to begin with, so it does not speak to healthy older adults.
Further reading
- Levine ME et al. Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population. Cell Metab 2014.[67]
- Phillips SM, Chevalier S, Leidy HJ. Protein "requirements" beyond the RDA. Appl Physiol Nutr Metab 2016.[68]
- Bauer J et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc 2013.[69]
- Moore DR et al. Protein ingestion to stimulate myofibrillar protein synthesis requires greater relative protein intakes in healthy older versus younger men. J Gerontol A Biol Sci Med Sci 2015.[70]
- Schoenfeld BJ, Aragon AA. How much protein can the body use in a single meal for muscle-building? J Int Soc Sports Nutr 2018.[71]
- Trommelen J et al. The anabolic response to protein ingestion during recovery from exercise has no upper limit in magnitude and duration in vivo in humans. Cell Rep Med 2023;4(12):101324.[72]
- Zhang X et al. Identification of a leucine-mediated threshold effect governing macrophage mTOR signalling and cardiovascular risk. Nature Metabolism 2024;6(2):359–377.[73]
- Mannick JB, Lamming DW. Targeting the biology of aging with mTOR inhibitors. Nature Aging 2023.[74]
- Naghshi S et al. Dietary intake of total, animal, and plant proteins and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis. BMJ 2020;370:m2412.[75]
- Ardisson Korat AV et al. Dietary protein intake in midlife in relation to healthy aging — results from the prospective Nurses' Health Study cohort. Am J Clin Nutr 2024;119(2):271–282.[76]
- Schüler R, Markova M et al. Similar dietary regulation of IGF-1 and IGF-binding proteins by animal and plant protein in subjects with type 2 diabetes. Eur J Nutr 2021.[77]
- Morton RW et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med 2018.[78]
- Deutz NEP et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr 2014;33(6):929–936.[79]
- Babygirija R, Lamming DW. The regulation of healthspan and lifespan by dietary amino acids. Transl Med Aging 2021.[80]
- Bouvard V et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol 2015 (IARC).[81]
- Hevia-Larraín V et al. High-protein plant-based diet versus a protein-matched omnivorous diet to support resistance training adaptations. Sports Med 2021.[82]
- Miller RA et al. Glycine supplementation extends lifespan of male and female mice. Aging Cell 2019.[83]
- Wolfe RR. Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? J Int Soc Sports Nutr 2017.[84]
- van Galen I et al. High protein intake causes gene-length-dependent transcriptional decline, shortens lifespan and accelerates ageing in progeroid DNA repair-deficient mice. npj Metab Health Dis 2025.[85]
- Held S et al. Maximizing Adaptations in Concurrent Training: An Umbrella Review of Meta-analyses. Sports Med 2026.[86]
- Raubenheimer D, Simpson SJ. Protein appetite as an integrator in the obesity system: the protein leverage hypothesis. Philos Trans R Soc Lond B Biol Sci 2023.[87]
- Regmi P, Heilbronn LK. Time-restricted eating: benefits, mechanisms, and challenges in translation. iScience 2020.[88]
- Devries MC et al. Changes in kidney function do not differ between healthy adults consuming higher- compared with lower- or normal-protein diets: a systematic review and meta-analysis. J Nutr 2018.[89]